Actively Recruiting
Evaluation of Cerebral, Hemodynamic and Neuronal Activities in Neonates in the Immediate Postpartum
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-05-13
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying how the brain's nervous and blood flow systems interact in newborns right after birth, focusing on neonates at risk of oxygen deprivation and brain injury. This research aims to improve understanding of cerebral oxygenation and neuronal activity during this critical transition period. The study targets full-term neonates between 36 and 41 weeks gestational age and monitors brain function immediately after delivery to detect early signs of problems. The study uses a single sensor placed on the newborn's scalp within five minutes after birth to record two key signals: the brain's electrical activity via electroencephalogram (EEG) and cerebral tissue oxygen levels using oxymetry. These signals will be analyzed simultaneously to examine their correlation over time and frequency, aiming to reveal how the brain and blood flow systems work together during those first crucial minutes after birth. Participants will have EEG and cerebral oxygenation recorded during the first five minutes post-delivery. Researchers will analyze how these signals correlate and assess any relation to the mode of delivery. The study involves no masking or randomization, focusing on detailed measurements during this immediate postpartum window. The total participation is brief, centered on the initial minutes after birth, with ongoing data analysis to identify potential early brain malfunctions.
CONDITIONS
Brief Title
Neonate Cerebral Activity in Immediate Post Partum
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Full term neonates between 36 and 41 weeks Gestational Age
You will not qualify if you...
- Premature neonates
- Neonates of twin pregnancy
- Suspicion of congenital malformation seen in antenatal ultrasound
- Any pathology requiring pediatric care from birth
- Newborns whose mothers had a chronic viral infection such as AIDS, hepatitis B or C, or who had a multidrug-resistant bacteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 5 minutes after birth
Participants undergo recording of cerebral activity using electroencephalogram and cerebral oxymetry within 5 minutes after birth.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
CHU Amiens
Amiens, France, 80054
Actively Recruiting
Research Team
F
Fabrice Wallois, Pr
J
Jean Gondry, Pr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here